Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of SKI2670 in Healthy Female Subjects
NCT02202408Phase 1Completed
- Sponsor
- SK Chemicals
- Start
- Jun 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in endometriosis comparing SKI2670 with Placebo (2 arms). Primary endpoint: Number of Participants with Adverse Events as a Measure of Safety and Tolerability. Started Jun 2014; status: completed.
02
Drugs
merigolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02202408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202408.